Aducanumab, amyloid, and culture wars
Those who thought that the US Food and Drug Administration (FDA) was a conservative regulator which maintained a high bar have been shocked by its approval of the anti-amyloid antibody…
Read Original Article: Aducanumab, amyloid, and culture wars »
